BTAI - CIK 0001720893
BioXcel Therapeutics, Inc. (BTAI) reported revenue of $642.00K for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $642.00K | -71.7% |
| FY 2024 | $2.27M | +64.2% |
| FY 2023 | $1.38M | +268.0% |
| FY 2022 | $375.00K | - |
BioXcel Therapeutics, Inc. (BTAI) reported revenue of $642.00K for fiscal year 2025, as filed in its audited annual report with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.